Antibiotic Treatment for Simple Infectious Colitis
For simple infectious colitis, oral metronidazole 500 mg three times daily for 10 days is the first-line antibiotic treatment, while oral vancomycin 125 mg four times daily for 10 days is recommended for severe cases or when metronidazole fails. 1, 2
Treatment Algorithm for Infectious Colitis
First-Line Treatment
- Metronidazole: 500 mg orally three times daily for 10 days 1
- Most cost-effective option
- Effective against most anaerobic bacteria including Clostridioides difficile
- Good tissue penetration and rapid bacterial killing 3
Second-Line/Severe Disease Treatment
Third-Line/Recurrent Disease Treatment
- Fidaxomicin: 200 mg orally twice daily for 10 days 1, 2
- Particularly useful for recurrent infections
- Note: Not associated with fewer recurrences in PCR ribotype 027 1
Special Considerations
Severity Assessment
Determine severity based on:
- Frequency of diarrhea (≥3 unformed stools in 24 hours)
- Fever
- Abdominal pain
- Leukocytosis
- Serum lactate levels (>5.0 mmol/L indicates severe disease) 1, 2
Treatment Failures and Recurrences
- For recurrent infections, consider:
Important Caveats
- Discontinue the inciting antibiotic if possible 1, 2
- Avoid antimotility agents during active infection 2
- Ensure adequate fluid and electrolyte replacement 2
- Implement infection control measures including contact precautions and hand hygiene with soap and water 2
- Monitor for complications such as toxic megacolon, perforation, and sepsis 1, 2
- Do not perform "test of cure" after treatment completion 2
Antibiotic Selection Pitfalls
- Metronidazole should not be used in severe or life-threatening disease 1
- Vancomycin use should be limited to appropriate cases to prevent development of vancomycin-resistant organisms 5
- Parenteral administration of vancomycin is not effective for C. difficile or staphylococcal enterocolitis; must be given orally 4
- Antibiotics most commonly associated with causing C. difficile colitis include clindamycin, fluoroquinolones, cephalosporins, and beta-lactam/beta-lactamase inhibitor combinations 2
By following this evidence-based approach to antibiotic selection for infectious colitis, you can optimize patient outcomes while minimizing the risk of treatment failure and recurrence.